Articles about 'Parkinson's disease'

Cambridge researchers are developing implants that could help repair the brain pathways damaged by Parkinson’s disease.

Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.

Cambridge scientists may have discovered a new way in which fasting helps reduce inflammation – a potentially damaging side-effect of the body’s immune system that underlies a number of chronic diseases.

Water – which makes up the majority of every cell in the body – plays a key role in how proteins, including those associated with Parkinson’s disease, fold, misfold, or clump together, according to a new study.

Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease.

7T MRI scanners could be used to help identify those patients with Parkinson’s disease and similar conditions most likely to benefit from new treatments for previously-untreatable symptoms, say scientists.

Scientists have made a ‘vital step’ towards understanding the origins of Parkinson’s disease – the fastest growing neurological condition in the world.

Researchers have identified the driving force behind a cellular process linked to neurodegenerative disorders such as Parkinson’s and motor neurone disease.

A prescription drug to treat high blood pressure has shown promise against conditions such as Parkinson’s, Huntington’s and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge.

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.